Symphogen AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb) mixture therapeutics to enhance the lives of patients with cancer and other diseases with significant unmet medical needs. Its product pipeline provides novel approaches to a wide range of cancer types including metastatic colorectal cancer (mCRC), glioblastoma (GBM), solid tumor malignancies and MET-amplified solid tumors and partner targets. It has collaborations for the development of antibody therapeutics in immuno-oncology with Shire and infectious disease area with Genentech. Symphogen has offices in Denmark and New Jersey, the US.

Symphogen AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symphogen A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Symphogen A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symphogen A/S, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Symphogen Raises USD76.6 Million in Venture Financing 10
Symphogen Raises US$54 Million In Expanded Venture Financing Round 11
Partnerships 12
Baxalta Enters into Agreement with Symphogen 12
Symphogen Enters Into Agreement With Open Monoclonal Technology 13
Symphogen A/S - Key Competitors 14
Symphogen A/S - Key Employees 15
Symphogen A/S - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables

List of Tables
Symphogen A/S, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symphogen A/S, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symphogen A/S, Deals By Therapy Area, 2012 to YTD 2018 8
Symphogen A/S, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symphogen Raises USD76.6 Million in Venture Financing 10
Symphogen Raises US$54 Million In Expanded Venture Financing Round 11
Baxalta Enters into Agreement with Symphogen 12
Symphogen Enters Into Agreement With Open Monoclonal Technology 13
Symphogen A/S, Key Competitors 14
Symphogen A/S, Key Employees 15
Symphogen A/S, Subsidiaries 16

List Of Figures

List of Figures
Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Symphogen A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Symphogen A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Symphogen AS - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Symphogen A/S (Symphogen) is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody (mAb)

USD 250 View Report

Symphogen A/S - Product Pipeline Review - 2016

Symphogen A/S - Product Pipeline Review - 2016Global Markets Directs, Symphogen A/S - Product Pipeline Review - 2016, provides an overview of the Symphogen A/Ss pharmaceutical research and development focus.

USD 1500 View Report

Cermaq Group AS - Strategic SWOT Analysis Review

Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Consumers Energy Co (CMS PR B) - Oil & Gas - Deals and Alliances Profile

Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available